Transcatheter Interventions Online 2021 - On Demand
Published: 20 April 2021
-
Views:
96271 -
Likes:
7
-
Views:
96271 -
Likes:
7
-
Up Next
-
1h 5m 56sPart 3 | Session 3 Live Cases and Discussion – Atherectomy Case / LAA Closure
-
1h 5m 25sPart 3 | Session 4 Session 3.3 – CONTROVERSIES 2 & Wrap-up
-
52m 27s
-
38m 10s
-
58m 59sPart 1 | Session 1 Introduction & Session 1.1 Presentations and Discussion – EXPANDING INDICATIONS IN TAVI Nicolas M Van Mieghem, Roxana Mehran, Lars Søndergaard, Didier Tchétché, David Hildick-Smith
-
1h 8m 51sPart 1 | Session 2 Live Cases and Discussion – TAVI Case Roxana Mehran, Nicolas M Van Mieghem, Lars Søndergaard, Didier Tchétché, David Hildick-Smith
-
55m 28sPart 1 | Session 3 Session 1.2 Presentations and Discussion – UPDATE AND OPPORTUNITIES IN TRANSCATHETER EDGE TO EDGE THERAPIES Azeem Latib, Kendra J Grubb, Holger Thiele, Lars Søndergaard, David Hildick-Smith
-
1h 13m 45sPart 1 | Session 4 Live Cases and Discussion – Edge-to-Edge Repair in TR / Edge-to-Edge Repair in MR & Wrap-up Nicolas M Van Mieghem, Azeem Latib, Kendra J Grubb, Holger Thiele, Lars Søndergaard, David Hildick-Smith
-
55m 13sPart 1 | Session 5 Satellite Symposium – TAVI Haemodynamics and Outcomes: Are We Measuring Appropriately? (This symposium was supported by an unrestricted educational grant from Edwards Lifesciences) Philippe Pibarot, Philip MacCarthy, Philippe Genereux, David Wood
-
59m 58sPart 2 | Session 1 Introduction & Session 2.1 Presentations and Discussion – CONTEMPORARY INSIGHTS IN IMAGING AND PHYSIOLOGY Azeem Latib, Roxana Mehran, Joost Daemen, Margaret McEntegart, David Hildick-Smith, Ajay J Kirtane
-
1h 1m 50sPart 2 | Session 2 Live Cases and Discussion – Complex PCI with OCT & Physiology / CTO with Imaging & Physiology Roxana Mehran, Joost Daemen, Margaret McEntegart, David Hildick-Smith, Ajay J Kirtane
-
59m 35sPart 2 | Session 3 Session 2.2 Presentations and Discussion – MECHANICAL CIRCULATORY SUPPORT Ajay J Kirtane, Kendra J Grubb, Holger Thiele, Azeem Latib, Nicolas M Van Mieghem
-
1h 8m 26sPart 2 | Session 4 Live Cases and Discussion – Complex PCI with MCS & Wrap-up Ajay J Kirtane, Kendra J Grubb, Holger Thiele, Azeem Latib, Nicolas M Van Mieghem
-
41m 27sPart 2 | Session 5 Technical Breakout – Expanding your transfemoral TAVI access options with IVL (Supported by Shockwave Medical) Nicolas M Van Mieghem, Joost Daemen
-
34m 46sPart 3 | Session 1 Introduction & Session 3.1 – KEYNOTE Nicolas M Van Mieghem, Roxana Mehran, Azeem Latib, Holger Thiele, Didier Tchétché, Martin B Leon
Overview
Following on from the success of 2020's inaugural edition, Transcatheter Interventions Online 2021 again brings together a world-class faculty to provide expert insight and educational learning on the latest developments in interventional management.
Combining expert opinion and discussion, presentations, and live cases from centres on both sides of the Atlantic, TIO 2021 delivers best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
Note, the live version of this session was CME accredited; this on-demand version is not.
Transcatheter Interventions Online 2021 was sponsored by the following companies:
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Coronary Heart Disease
Part 3
Day Three: Controversies in Current Practice
Faculty Biographies
Didier Tchétché
Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004. From 2004 to 2005, he completed a 12-month fellowship period in the Hemodynamic and Interventional Cardiology department of Clinique Pasteur in Toulouse and from 2005 to 2007 he was Head Assistant at the intensive care unit of Bichât Hospital in Paris.
In 2008, he joined the interventional cardiovascular group in Clinique Pasteur, Toulouse, and he is currently Head of the Structural programme with an experience of more than 5000 TAVI procedures. His main areas of interest are coronary interventions and valvular heart disease. He has been actively involved in many clinical trials involving new technologies and devices in the field of interventional cardiology.